Search for a doctor

Peter J. Schoettler, M.D.

  1. Pediatric Hematologist / Oncologist

Peter John Schoettler, M.D., is a pediatric hematologist and oncologist at Mayo Clinic in Rochester, Minnesota, providing expert care for children with cancer and blood disorders. Dr. Schoettler has a particular clinical focus on rare tumors, renal tumors and conditions associated with DICER1 syndrome. He partners closely with families to deliver individualized treatment using advanced therapies and a multidisciplinary approach, ensuring comprehensive care for each child.

Dr. Schoettler also serves as an Assistant Professor of Pediatrics at the Mayo Clinic College of Medicine and Science and Program Director for the Pediatric Hematology Oncology Fellowship. He is board-certified in pediatrics and pediatric hematology/oncology.

Outside of his clinical role, Dr. Schoettler enjoys woodworking, playing fantasy football and spending time with his family and their dog, Waffles.

Areas of expertise

Dr. Schoettler specializes in caring for children with rare and complex cancers. His clinical expertise includes:

  • Sarcomas: Diagnosis and treatment of pediatric soft tissue and bone sarcomas
  • Wilms tumor: Comprehensive care for this rare childhood kidney cancer
  • Neuroblastoma: Management of neuroblastoma in children and adolescents
  • Pleuropulmonary blastoma: Specialized treatment and follow-up, including care for DICER1 syndrome
  • Lumbar punctures: Diagnostic and therapeutic procedures for pediatric oncology patients
  • Rare tumor management: Focused expertise in genetic cancer syndromes and uncommon pediatric tumors

Research and expertise

Dr. Schoettler is committed to advancing care for children with rare tumors, renal cancers, and hereditary cancer syndromes. He is actively involved in education as the Program Director for Mayo Clinic’s Pediatric Hematology Oncology Fellowship, fostering the development of future leaders in pediatric oncology. His dedication to research and clinical excellence has earned recognition from national professional societies, including the American Society of Pediatric Hematology/Oncology.

  1. Anaplastic kidney sarcoma
  2. DICER1 syndrome
  3. Ewing sarcoma
  4. Neuroblastoma
  5. Osteosarcoma
  6. Pleuropulmonary blastoma
  7. Sarcoma
  8. Wilms' tumor
  1. 2021
    Fellow - Pediatric Hematology/OncologyUT Southwestern Medical Center
  2. 2018
    Internship/ResidencyUniversity of California-Irvine/Children’s Hospital of Orange County
  3. 2015
    MDUniversity of Minnesota
  4. 2011
    BS - ChemistryUniversity of Minnesota

Certifications

  1. 2023
    Pediatric Hematology-OncologyAmerican Board of Pediatrics
  2. 2018
    PediatricsAmerican Board of Pediatrics

Awards and honors

  1. 2021
    Early Career AwardThe American Society of Pediatric Hematology/Oncology (ASPHO)
  2. 2018
    Director’s Award, UCI/CHOC Pediatrics ResidencyUniversity of California-Irvine/Children’s Hospital of Orange County
  3. 2015
    People’s Choice Award Poster at Annual MeetingMN American Academy of Pediatrics

Professional memberships

  1. 2024 - present
    MemberChildren's Oncology Group
  2. 2021 - present
    MemberChildren's Oncology Group
  3. 2020 - 2024
    MemberInternational PPB Prospective Treatment Trial Working Groups
  4. 2019 - present
    MemberAmerican Society of Clinical Oncology
  5. 2018 - present
    MemberAmerican Society of Pediatric Hematology/Oncology
  6. 2018 - present
    MemberRare Tumors, Renal Tumors, and Young Investigators, Children's Oncology Group
  7. 2015 - 2018
    Co-ChairChildren’s Hospital Orange County

Publications